We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We prioritise innovation in vaccines and specialty medicines to prevent and treat disease.
The ILC5 conference will provide a perfect opportunity to discuss the latest developments in the field from fundamental discoveries to translational studies and we look forward to establishing partnerships with the industry to support the delivery of this key international event.
We look forward to working with you to maximise the return on your investment and create a successful package to meet your organisation’s objectives and budget.